ResearcherNankai UniversityActive in the last 2 years

Xingwei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-0904-4485; OpenAlex author ID A5101820266. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Tumor-penetrating iRGD facilitates penetration of poly(floxuridine-ketal)-based nanomedicine for enhanced pancreatic cancer therapy. Co-author DOI 10.1016/j.jconrel.2024.04.004 ↗
Stromal Homeostasis-Restoring Nanomedicine Enhances Pancreatic Cancer Chemotherapy. Co-author DOI 10.1021/acs.nanolett.2c03663 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Na Yu · 2 shared papers, 2022–2024 · strength 0.41
- Paper Tumor-penetrating iRGD facilitates penetration of poly(floxuridine-ketal)-based nanomedicine for enhanced pancreatic ca… DOI 10.1016/j.jconrel.2024.04.004 ↗
- Paper Stromal Homeostasis-Restoring Nanomedicine Enhances Pancreatic Cancer Chemotherapy. DOI 10.1021/acs.nanolett.2c03663 ↗
Shutao Guo · 2 shared papers, 2022–2024 · strength 0.41
- Paper Tumor-penetrating iRGD facilitates penetration of poly(floxuridine-ketal)-based nanomedicine for enhanced pancreatic ca… DOI 10.1016/j.jconrel.2024.04.004 ↗
- Paper Stromal Homeostasis-Restoring Nanomedicine Enhances Pancreatic Cancer Chemotherapy. DOI 10.1021/acs.nanolett.2c03663 ↗
Xing‐Jie Liang · 1 shared paper, 2022 · strength 0.16
- Paper Stromal Homeostasis-Restoring Nanomedicine Enhances Pancreatic Cancer Chemotherapy. DOI 10.1021/acs.nanolett.2c03663 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.